Leiden, Netherlands

Onno C Meijer

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Corcept Therapeutics Incorporated. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Onno C Meijer. Retrieved from https://idiyas.com/inventor/onno-c-meijer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Onno C Meijer: Innovator in Fatty Liver Disease Treatment

Introduction

Onno C Meijer is a prominent inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical treatments, particularly focusing on fatty liver disease. With a total of 4 patents to his name, Meijer's work is paving the way for innovative therapeutic solutions.

Latest Patents

One of Meijer's latest patents involves a treatment for fatty liver disease using glucocorticoid and mineralocorticoid receptor antagonists. This invention provides a novel approach to treating fatty liver disease through a class of pyrimidinedione cyclohexyl compounds. His research aims to improve patient outcomes and offer new hope for those affected by this condition.

Career Highlights

Throughout his career, Onno C Meijer has been associated with Corcept Therapeutics Incorporated, where he has been instrumental in advancing research and development in the field of liver diseases. His expertise and innovative mindset have contributed to the company's mission of providing effective treatments.

Collaborations

Meijer has collaborated with notable professionals in the industry, including Joseph K Belanoff and Hazel Joan Hunt. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking treatments.

Conclusion

Onno C Meijer stands out as a key figure in the innovation of treatments for fatty liver disease. His dedication to research and development continues to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…